On July 15, Intuitive Surgical rose 3.14% in regular trading, trading at $391.32 per share with turnover of $3.64 billion. The stock rebounded sharply after touching a 52-week low earlier in the session, as the broader medical device sector staged a recovery and investors positioned ahead of the company's earnings report scheduled for July 16 after market close.

The rebound follows a 3.04% decline on July 14, when multiple investment banks cut their price targets. BTIG Research lowered its target to $512 from $574, while RBC cut to $600 from $650, both maintaining bullish ratings. BMO Capital Markets highlighted that Intuitive Surgical currently trades at approximately a 31% discount to its three-year historical P/E multiple, attributing sector weakness to capital rotation toward AI rather than fundamental deterioration, and called it a historic buying opportunity.

The company reported strong Q1 results in April, with revenue rising 23% year-over-year to $2.77 billion and adjusted EPS of $2.50, both exceeding expectations. The consensus average price target stands at $563.36 with an overweight rating.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)